Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer.

Heeren AM, van Luijk IF, Lakeman J, Pocorni N, Kole J, de Menezes RX, Kenter GG, Bosse T, de Kroon CD, Jordanova ES.

Cancer Immunol Immunother. 2019 Oct 15. doi: 10.1007/s00262-019-02412-x. [Epub ahead of print]

PMID:
31616965
2.

Prospective validation of craniocaudal tumour size on MR imaging compared to histoPAthology in patients with uterine cervical cancer: The MPAC study.

de Boer P, Spijkerboer AM, Bleeker MCG, van Lonkhuijzen LRCW, Monraats MA, Nederveen AJ, van de Vijver MJ, Kenter GG, Bel A, Rasch CRN, Stoker J, Stalpers LJA.

Clin Transl Radiat Oncol. 2019 Jun 15;18:9-15. doi: 10.1016/j.ctro.2019.06.004. eCollection 2019 Sep.

3.

Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study.

Kremer WW, Berkhof J, Bleeker MC, Heideman DA, van Trommel NE, van Baal MW, Verhoeve HR, Meijer CJ, Kenter GG.

BMJ Open. 2019 Jul 9;9(7):e029017. doi: 10.1136/bmjopen-2019-029017.

4.

The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.

van Baal JOAM, Van de Vijver KK, Algera MD, van der Aa MA, Sonke GS, van Driel WJ, Kenter GG, Amant FC, Lok CAR.

Gynecol Oncol. 2019 Jun;153(3):562-567. doi: 10.1016/j.ygyno.2019.03.257. Epub 2019 Apr 1.

PMID:
30948193
5.

Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer.

van de Vrie R, Rutten MJ, Asseler JD, Leeflang MM, Kenter GG, Mol BWJ, Buist M.

Cochrane Database Syst Rev. 2019 Mar 23;3:CD009786. doi: 10.1002/14651858.CD009786.pub3.

PMID:
30907434
6.

Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines.

Vermeulen RFM, Korse CM, Kenter GG, Brood-van Zanten MMA, Beurden MV.

Climacteric. 2019 Aug;22(4):352-360. doi: 10.1080/13697137.2019.1582622. Epub 2019 Mar 25.

PMID:
30905183
7.

Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels.

Heeren AM, Rotman J, Stam AGM, Pocorni N, Gassama AA, Samuels S, Bleeker MCG, Mom CH, Zijlmans HJMAA, Kenter GG, Jordanova ES, de Gruijl TD.

J Immunother Cancer. 2019 Feb 12;7(1):43. doi: 10.1186/s40425-019-0526-z.

8.

HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme.

Polman NJ, Snijders PJF, Kenter GG, Berkhof J, Meijer CJLM.

Prev Med. 2019 Feb;119:108-117. doi: 10.1016/j.ypmed.2018.12.021. Epub 2018 Dec 27. Review.

9.

Does anti-Müllerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study.

Vermeulen RFM, van Beurden M, Gaarenstroom KN, Teunis T, Kieffer JM, Aaronson NK, Kenter GG, Korse CM.

Climacteric. 2018 Dec;21(6):574-580. doi: 10.1080/13697137.2018.1512965. Epub 2018 Oct 8.

PMID:
30295077
10.
11.

HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions.

Zummeren MV, Kremer WW, Leeman A, Bleeker MCG, Jenkins D, Sandt MV, Doorbar J, Heideman DAM, Steenbergen RDM, Snijders PJF, Kenter GG, Quint WGV, Berkhof J, Meijer CJLM.

Mod Pathol. 2018 Dec;31(12):1842-1850. doi: 10.1038/s41379-018-0101-z. Epub 2018 Aug 22.

PMID:
30135508
12.

Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer.

Heeren AM, van Dijk I, Berry DRAI, Khelil M, Ferns D, Kole J, Musters RJP, Thijssen VL, Mom CH, Kenter GG, Bleeker MCG, de Gruijl TD, Jordanova ES.

Front Immunol. 2018 Jul 11;9:1598. doi: 10.3389/fimmu.2018.01598. eCollection 2018.

13.

Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period.

Derks M, van der Velden J, de Kroon CD, Nijman HW, van Lonkhuijzen LRCW, van der Zee AGJ, Zwinderman AH, Kenter GG.

Int J Gynecol Cancer. 2018 May;28(4):757-763. doi: 10.1097/IGC.0000000000001228.

PMID:
29595758
14.

The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.

Tajik P, van de Vrie R, Zafarmand MH, Coens C, Buist MR, Vergote I, Bossuyt PMM, Kenter GG.

Int J Gynecol Cancer. 2018 Mar;28(3):453-458. doi: 10.1097/IGC.0000000000001186.

PMID:
29324537
15.

Supravaginal hysterectomy in Curaçao prevalence and impact on screening for cervical cancer.

Hooi DJ, Meijer CJLM, Witte BI, Bravio IG, Pinedo HM, Kenter GG.

Prev Med Rep. 2017 Nov 8;8:238-241. doi: 10.1016/j.pmedr.2017.11.005. eCollection 2017 Dec.

16.

Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

van Baal JOAM, van Noorden CJF, Nieuwland R, Van de Vijver KK, Sturk A, van Driel WJ, Kenter GG, Lok CAR.

J Histochem Cytochem. 2018 Feb;66(2):67-83. doi: 10.1369/0022155417742897. Epub 2017 Nov 22. Review.

17.

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.

Hooi DJ, Lissenberg-Witte BI, de Koning MNC, Pinedo HM, Kenter GG, Meijer CJ, Quint WG.

Sex Transm Infect. 2018 Jun;94(4):263-267. doi: 10.1136/sextrans-2017-053109. Epub 2017 Oct 11.

18.

Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer.

van de Vrie R, van Meurs HS, Rutten MJ, Naaktgeboren CA, Opmeer BC, Gaarenstroom KN, van Gorp T, Ter Brugge HG, Hofhuis W, Schreuder HWR, Arts HJG, Zusterzeel PLM, Pijnenborg JMA, van Haaften M, Engelen MJA, Boss EA, Vos MC, Gerestein KG, Schutter EMJ, Kenter GG, Bossuyt PMM, Mol BW, Buist MR.

Gynecol Oncol. 2017 Sep;146(3):449-456. doi: 10.1016/j.ygyno.2017.06.019. Epub 2017 Jun 20.

PMID:
28645428
19.

Impact of risk-reducing salpingo-oophorectomy in premenopausal women.

Vermeulen RFM, Beurden MV, Korse CM, Kenter GG.

Climacteric. 2017 Jun;20(3):212-221. doi: 10.1080/13697137.2017.1285879. Epub 2017 Mar 2. Review.

PMID:
28509627
20.

Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.

Derks M, Groenman FA, van Lonkhuijzen LRCW, Schut PC, Westerveld H, van der Velden J, Kenter GG.

Int J Gynecol Cancer. 2017 Jun;27(5):1015-1020. doi: 10.1097/IGC.0000000000000974.

PMID:
28498252
21.

A Controlled Study on Vaginal Blood Flow During Sexual Arousal Among Early-Stage Cervical Cancer Survivors Treated With Conventional Radical or Nerve-Sparing Surgery With or Without Radiotherapy.

Bakker RM, Pieterse QD, van Lonkhuijzen LRCW, Trimbos BJBMZ, Creutzberg CL, Kenter GG, de Kroon CD, Ter Kuile MM.

Int J Gynecol Cancer. 2017 Jun;27(5):1051-1057. doi: 10.1097/IGC.0000000000000986.

PMID:
28498243
22.

HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.

Samuels S, Marijne Heeren A, Zijlmans HJMAA, Welters MJP, van den Berg JH, Philips D, Kvistborg P, Ehsan I, Scholl SME, Nuijen B, Schumacher TNM, van Beurden M, Jordanova ES, Haanen JBAG, van der Burg SH, Kenter GG.

Cancer Immunol Immunother. 2017 Sep;66(9):1163-1173. doi: 10.1007/s00262-017-2006-y. Epub 2017 Apr 27.

PMID:
28451790
23.

Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.

Stiekema A, Lok C, Korse CM, van Driel WJ, van der Noort V, Kenter GG, Van de Vijver KK.

Virchows Arch. 2017 Jun;470(6):655-664. doi: 10.1007/s00428-017-2115-1. Epub 2017 Apr 11.

PMID:
28401338
24.

Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.

van Meir H, Nout RA, Welters MJ, Loof NM, de Kam ML, van Ham JJ, Samuels S, Kenter GG, Cohen AF, Melief CJ, Burggraaf J, van Poelgeest MI, van der Burg SH.

Oncoimmunology. 2016 Dec 23;6(2):e1267095. doi: 10.1080/2162402X.2016.1267095. eCollection 2017.

25.

Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer.

Stiekema A, Van de Vijver KK, Boot H, Broeks A, Korse CM, van Driel WJ, Kenter GG, Lok CA.

Cancer Cytopathol. 2017 Mar;125(3):197-204. doi: 10.1002/cncy.21811. Epub 2017 Feb 15.

26.

New biomarkers in epithelial ovarian cancer: needed or redundant?

Stiekema A, Korse CM, Aaronson NK, van Driel WJ, Kenter GG, Lok CAR.

Eur J Gynaecol Oncol. 2017;38(3):356-360.

PMID:
29693872
27.

Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.

Rutten MJ, van Meurs HS, van de Vrie R, Gaarenstroom KN, Naaktgeboren CA, van Gorp T, Ter Brugge HG, Hofhuis W, Schreuder HW, Arts HJ, Zusterzeel PL, Pijnenborg JM, van Haaften M, Fons G, Engelen MJ, Boss EA, Vos MC, Gerestein KG, Schutter EM, Opmeer BC, Spijkerboer AM, Bossuyt PM, Mol BW, Kenter GG, Buist MR.

J Clin Oncol. 2017 Feb 20;35(6):613-621. doi: 10.1200/JCO.2016.69.2962. Epub 2016 Dec 28.

PMID:
28029317
28.

Long-Term Morbidity and Quality of Life in Cervical Cancer Survivors: A Multicenter Comparison Between Surgery and Radiotherapy as Primary Treatment.

Derks M, van Lonkhuijzen LR, Bakker RM, Stiggelbout AM, de Kroon CD, Westerveld H, Roovers JP, Kenter GG, Ter Kuile MM.

Int J Gynecol Cancer. 2017 Feb;27(2):350-356. doi: 10.1097/IGC.0000000000000880.

PMID:
27984376
29.

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.

Ferns DM, Heeren AM, Samuels S, Bleeker MCG, de Gruijl TD, Kenter GG, Jordanova ES.

J Immunother Cancer. 2016 Nov 15;4:78. doi: 10.1186/s40425-016-0184-3. eCollection 2016.

30.

The histophysiology and pathophysiology of the peritoneum.

van Baal JO, Van de Vijver KK, Nieuwland R, van Noorden CJ, van Driel WJ, Sturk A, Kenter GG, Rikkert LG, Lok CA.

Tissue Cell. 2017 Feb;49(1):95-105. doi: 10.1016/j.tice.2016.11.004. Epub 2016 Nov 13. Review.

PMID:
27890350
31.

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study.

Samuels S, Balint B, von der Leyen H, Hupé P, de Koning L, Kamoun C, Luscap-Rondof W, Wittkop U, Bagrintseva K, Popovic M, Kereszt A, Berns E, Kenter GG, Jordanova ES, Kamal M, Scholl S.

Br J Cancer. 2016 Dec 6;115(12):1575-1583. doi: 10.1038/bjc.2016.340. Epub 2016 Nov 22.

32.

Sexual distress and associated factors among cervical cancer survivors: A cross-sectional multicenter observational study.

Bakker RM, Kenter GG, Creutzberg CL, Stiggelbout AM, Derks M, Mingelen W, Kroon CD, Vermeer WM, Ter Kuile MM.

Psychooncology. 2017 Oct;26(10):1470-1477. doi: 10.1002/pon.4317. Epub 2016 Dec 6.

PMID:
27862635
33.

Incidence of lymph node metastases in clinical early-stage mucinous and seromucinous ovarian carcinoma: a retrospective cohort study.

van Baal J, Van de Vijver KK, Coffelt SB, van der Noort V, van Driel WJ, Kenter GG, Buist MR, Lok C.

BJOG. 2017 Feb;124(3):486-494. doi: 10.1111/1471-0528.14425. Epub 2016 Nov 16.

34.

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.

Veluchamy JP, Heeren AM, Spanholtz J, van Eendenburg JD, Heideman DA, Kenter GG, Verheul HM, van der Vliet HJ, Jordanova ES, de Gruijl TD.

Cancer Immunol Immunother. 2017 Jan;66(1):51-61. doi: 10.1007/s00262-016-1919-1. Epub 2016 Oct 25.

35.

Human Leukocyte Antigen-DR Expression is Significantly Related to an Increased Disease-Free and Disease-Specific Survival in Patients With Cervical Adenocarcinoma.

Samuels S, Spaans VM, Osse M, Peters LAW, Kenter GG, Fleuren GJ, Jordanova ES.

Int J Gynecol Cancer. 2016 Oct;26(8):1503-1509. doi: 10.1097/IGC.0000000000000783.

PMID:
30814136
36.

Human Leukocyte Antigen-DR Expression is Significantly Related to an Increased Disease-Free and Disease-Specific Survival in Patients With Cervical Adenocarcinoma.

Samuels S, Spaans VM, Osse M, Peters LA, Kenter GG, Fleuren GJ, Jordanova ES.

Int J Gynecol Cancer. 2016 Oct;26(8):1503-1509.

PMID:
27654088
37.

Long-term Pelvic Floor Function and Quality of Life After Radical Surgery for Cervical Cancer: A Multicenter Comparison Between Different Techniques for Radical Hysterectomy With Pelvic Lymphadenectomy.

Derks M, van der Velden J, Frijstein MM, Vermeer WM, Stiggelbout AM, Roovers JP, de Kroon CD, Ter Kuile MM, Kenter GG.

Int J Gynecol Cancer. 2016 Oct;26(8):1538-43. doi: 10.1097/IGC.0000000000000776.

PMID:
27465892
38.

Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype.

McConechy MK, Färkkilä A, Horlings HM, Talhouk A, Unkila-Kallio L, van Meurs HS, Yang W, Rozenberg N, Andersson N, Zaby K, Bryk S, Bützow R, Halfwerk JB, Hooijer GK, van de Vijver MJ, Buist MR, Kenter GG, Brucker SY, Krämer B, Staebler A, Bleeker MC, Heikinheimo M, Kommoss S, Blake Gilks C, Anttonen M, Huntsman DG.

J Natl Cancer Inst. 2016 Jun 13;108(11). pii: djw134. doi: 10.1093/jnci/djw134. Print 2016 Nov. Erratum in: J Natl Cancer Inst. 2017 Apr 1;109(4):.

39.

Uterine serous carcinoma: a historic evaluation of therapy.

de Leeuw Fa, Rijcken Fe, Trum Jw, van der Noort V, Tjon-Kon-Fat Ri, Bleeker Mc, Kenter Gg.

Eur J Gynaecol Oncol. 2016;37(2):211-5.

PMID:
27172747
40.

Careful Dissection of the Distal Ureter Is Highly Important in Nerve-sparing Radical Pelvic Surgery: A 3D Reconstruction and Immunohistochemical Characterization of the Vesical Plexus.

Kraima AC, Derks M, Smit NN, van de Velde CJ, Kenter GG, DeRuiter MC.

Int J Gynecol Cancer. 2016 Jun;26(5):959-66. doi: 10.1097/IGC.0000000000000709.

PMID:
27101584
41.

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.

Welters MJ, van der Sluis TC, van Meir H, Loof NM, van Ham VJ, van Duikeren S, Santegoets SJ, Arens R, de Kam ML, Cohen AF, van Poelgeest MI, Kenter GG, Kroep JR, Burggraaf J, Melief CJ, van der Burg SH.

Sci Transl Med. 2016 Apr 13;8(334):334ra52. doi: 10.1126/scitranslmed.aad8307.

PMID:
27075626
42.

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.

Heeren AM, Punt S, Bleeker MC, Gaarenstroom KN, van der Velden J, Kenter GG, de Gruijl TD, Jordanova ES.

Mod Pathol. 2016 Jul;29(7):753-63. doi: 10.1038/modpathol.2016.64. Epub 2016 Apr 8.

43.

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.

van Poelgeest MI, Welters MJ, Vermeij R, Stynenbosch LF, Loof NM, Berends-van der Meer DM, Löwik MJ, Hamming IL, van Esch EM, Hellebrekers BW, van Beurden M, Schreuder HW, Kagie MJ, Trimbos JB, Fathers LM, Daemen T, Hollema H, Valentijn AR, Oostendorp J, Oude Elberink JH, Fleuren GJ, Bosse T, Kenter GG, Stijnen T, Nijman HW, Melief CJ, van der Burg SH.

Clin Cancer Res. 2016 May 15;22(10):2342-50. doi: 10.1158/1078-0432.CCR-15-2594. Epub 2016 Jan 26.

44.

Results of radical surgery in women with stage IB2/IIA2 cervical cancer.

Derks M, Biewenga P, van der Velden J, Kenter GG, Stalpers LJ, Buist MR.

Acta Obstet Gynecol Scand. 2016 Feb;95(2):166-72. doi: 10.1111/aogs.12819. Epub 2015 Dec 18.

PMID:
26575692
45.

Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.

Heeren AM, de Boer E, Bleeker MC, Musters RJ, Buist MR, Kenter GG, de Gruijl TD, Jordanova ES.

Oncotarget. 2015 Oct 20;6(32):32484-93. doi: 10.18632/oncotarget.5398.

46.

Cervical cancer survivors' and partners' experiences with sexual dysfunction and psychosexual support.

Vermeer WM, Bakker RM, Kenter GG, Stiggelbout AM, Ter Kuile MM.

Support Care Cancer. 2016 Apr;24(4):1679-87. doi: 10.1007/s00520-015-2925-0. Epub 2015 Sep 28.

47.

Fertility preservation: a challenge for IVF-clinics.

Dahhan T, Mol F, Kenter GG, Balkenende EM, de Melker AA, van der Veen F, Dancet EA, Goddijn M.

Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:78-84. doi: 10.1016/j.ejogrb.2015.08.024. Epub 2015 Aug 28.

PMID:
26342681
48.

Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.

van Meurs HS, van der Velden J, Buist MR, van Driel WJ, Kenter GG, van Lonkhuijzen LR.

Acta Obstet Gynecol Scand. 2015 Nov;94(11):1269-75. doi: 10.1111/aogs.12720. Epub 2015 Sep 15.

PMID:
26230362
49.

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.

Dijkgraaf EM, Santegoets SJ, Reyners AK, Goedemans R, Wouters MC, Kenter GG, van Erkel AR, van Poelgeest MI, Nijman HW, van der Hoeven JJ, Welters MJ, van der Burg SH, Kroep JR.

Ann Oncol. 2015 Oct;26(10):2141-9. doi: 10.1093/annonc/mdv309. Epub 2015 Jul 27.

PMID:
26216383
50.

CD14+ macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?

Heeren AM, Kenter GG, Jordanova ES, de Gruijl TD.

Oncoimmunology. 2015 May 7;4(6):e1009296. eCollection 2015 Jun.

Supplemental Content

Loading ...
Support Center